Self-funded employers face skyrocketing prescription benefit costs driven almost exclusively by specialty drug claims. In fact, a new drug claim can easily double, triple, or quadruple pharmacy spend for employers.
RxPharmacy Assurance’s stop-loss supplement is designed specifically for pharmacy risk associated with conditions that have high-cost prescription therapies and provides multi-year protection that extends beyond traditional stop-loss coverage. Our supplemental stop-loss solution can help insurance brokers reduce their self-funded clients’ total cost of risk, offering them a way to limit their specialty exposure, potentially obtain lower stop-loss premiums, and make their prescription benefits more affordable.